WO2014205882A1 - High-fidelity dna polymerase, and preparation and use thereof - Google Patents
High-fidelity dna polymerase, and preparation and use thereof Download PDFInfo
- Publication number
- WO2014205882A1 WO2014205882A1 PCT/CN2013/079428 CN2013079428W WO2014205882A1 WO 2014205882 A1 WO2014205882 A1 WO 2014205882A1 CN 2013079428 W CN2013079428 W CN 2013079428W WO 2014205882 A1 WO2014205882 A1 WO 2014205882A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna polymerase
- amino acid
- seq
- shows
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
Definitions
- the invention belongs to the field of genetic engineering and relates to a high fidelity DNA polymerase and its preparation and application. Background technique
- DNA polymerases are widely used in molecular biology research, such as DNA sequencing, labeling, mutation, and nucleic acid amplification.
- Heat-resistant DNA polymerase is not attenuated under the conditions of high temperature denaturation of nucleic acid due to its thermal stability, and is a commonly used enzyme for nucleic acid amplification.
- DNA polymerase can be divided into six major groups: A, B, C, D, X and Y.
- the heat-resistant DNA polymerase mainly belongs to group A and group B, and has similar biological properties.
- A-group DNA polymerase is Taq DNA polymerase, which is isolated from the genome of The s aquaticus YT-1, having 5,-3, exonuclease activity and 5,-3, DNA polymerase activity. Its strain is grown in hot springs around 75 °C. Because it can withstand high temperature denaturation, it has been widely used in PCR since its discovery. It has been developed into a variety of kits; later studies have been isolated from other species. A variety of Group A DNA polymerases have emerged, but because they do not have the exonuclease-correcting activity of 3,-5, it is easy to incorporate the wrong base during amplification, resulting in the inability to faithfully amplify the template until the B group.
- the discovery of DNA polymerases made it possible to amplify templates with high fidelity.
- the B-group DNA polymerase is mainly isolated from archaea, including the archaea, the archaea, the cyanobacteria and the archaea, which have higher thermal stability, and the 3,-5, exonuclease-correcting activity can be recognized.
- the bases in the extended strand are incorrectly incorporated, and they are excised, and the DNA polymerase activity is added as a base complementary to the template, thereby ensuring high consistency between the newly amplified strand and the template.
- Hyperthermophilic archaea has strict anaerobic and hyperthermophilic growth characteristics, such as PyrocHciium and ⁇ awc ⁇ ym? species can grow at 10 ° C, but below 80 ° C can not grow; from Daxi >Ofob ⁇ /M an7 isolated from the 3650 m superheated chimney of the mid-ocean ridge is the most heat-resistant archaea known at present, which can be increased at high temperatures up to 113 ° C, and stopped below 90 ° C. Growing. Many DNA polymerases have been isolated from the OCOCO« and 73 ⁇ 4er ococo « genus.
- Pfo DNA polymerase is a thermostable DNA polymerase derived from ⁇ racoco ⁇ /Mn'om?, having 5,-3, DNA polymerase activity and exonuclease activity of 3,-5. Since Pfu DNA polymerase has exonuclease activity of 3,-5, the probability of error in nucleic acid amplification is greatly reduced, and the fidelity is about 6 times that of Taq DNA polymerase.
- Pfo DNA polymerase is usually used as the preferred high-fidelity DNA polymerase for high-fidelity amplification of nucleic acids.
- Pfo DNA polymerase requires high structure, purity and concentration of primers and samples. The reaction sensitivity is low and the amplification efficiency is low, which limits the use and promotion of Pfu DNA polymerase. Summary of the invention
- an object of the present invention is to provide a high-sensitivity, high-amplification high-fidelity DNA polymerase, and its preparation and use.
- the present invention uses the following technical solutions:
- the present invention provides a high-fidelity DNA polymerase, designated Tco DNA polymerase, having any one of the amino acid sequences shown in (1), (II):
- the invention provides a Tco DNA polymerase for use in nucleic acid amplification, and the Tco DNA polymerase has any one of the amino acid sequences shown by (I) and (II):
- the present invention provides a DNA molecule encoding Tco DNA polymerase, which has I, Any one of the nucleotide sequences shown in II:
- I has the nucleotide sequence shown in SEQ ID NO: 2;
- nucleotide sequence obtained by substituting, deleting or adding one or more bases of the nucleotide sequence shown by SEQ ID NO: 2;
- TcoDNA polymerase has any one of the amino acid sequences shown in (1) and (II):
- the present invention provides a recombinant vector comprising a DNA molecule encoding a Tco DNA polymerase having any one of the nucleotide sequences represented by I and II: I having the core represented by SEQ ID NO: Glycosidic acid sequence;
- nucleotide sequence obtained by substituting, deleting or adding one or more bases of the nucleotide sequence shown by SEQ ID NO: 2;
- the Tco DNA polymerase has any one of the amino acid sequences shown in (I) and (II): (I) having the amino acid sequence of SEQ ID NO: 1;
- the above recombinant vector is a recombinant vector containing a T7 promoter.
- the present invention provides a PCR amplification kit comprising Tco DNA polymerase having any one of the amino acid sequences shown in (1) and (II):
- the present invention also provides a method for preparing a high-fidelity DNA polymerase, comprising the steps of: obtaining a DNA molecule having an amino acid sequence encoding as defined in (I) or (II); and merging the above DNA molecule with an expression vector to construct a recombinant Expression vector;
- (I) is: having the amino acid sequence of SEQ ID NO: 1;
- ( ⁇ ) is: an amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
- DNA molecule having an amino acid sequence as defined in (I) or (II), specifically having any one of the nucleotide sequences shown by I, II:
- I has the nucleotide sequence shown in SEQ ID NO: 2;
- nucleotide sequence obtained by substituting, deleting or adding one or more bases of the nucleotide sequence shown by SEQ ID NO: 2.
- a DNA molecule having an amino acid sequence encoding as defined in (I) or (II) is obtained, specifically, the above DNA molecule is recombinantly constructed from the hyperthermophilic archaea Thermococcus coalescens; the above hyperthermophilic ancient The fungus was purchased from the Japan Collection of Microorganisms and Cultures, and its deposit number is JCM: 12540. It is isolated from the ultra-high temperature seawater of the Shuiyuanhai Mountain of the Izu Ogasawara, and it is an irregular spherical shape of 0.5-2 ⁇ . It can be fused during the exponential growth phase. It is a fusion cell of about 5 ⁇ ; the bacteria is grown at 57-90 ° C, pH 5.2-8.7, its optimum pH is 6.5, and the optimal growth temperature is 87 ° C, which has super thermophilic growth characteristics;
- (I) is: having the amino acid sequence of SEQ ID NO: 1;
- ( ⁇ ) is: an amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
- the host cell used in the preparation method of the high fidelity DNA polymerase is a prokaryotic system host cell.
- the purification operation in a method for preparing a high-fidelity DNA polymerase, specifically, purification using a gel medium.
- a method of making Tco DNA polymerase is specifically:
- the transformant is expanded and used to prepare the high-fidelity DNA polymerase after induction; (5) the high-fidelity DNA polymerase is obtained by sequentially purifying using a nickel gel medium and a heparin chromatography column.
- the present invention provides a high fidelity DNA polymerase, a preparation method thereof and use in nucleic acid amplification.
- the high-fidelity DNA polymerase has the amino acid sequence shown in SEQ ID NO: 1, or the amino acid sequence obtained by substituting, deleting or adding one or more amino acids to the amino acid sequence shown in SEQ ID NO: 1.
- the experimental data show that the purity of the high-fidelity DNA polymerase prepared by the preparation method disclosed in the present invention is over 95%, and the high-fidelity DNA polymerase provided by the present invention can be expanded compared with the Pfu high-fidelity DNA polymerase.
- FIG. 1 shows the results of purification of Tco DNA polymerase; wherein Lane 1 shows purified Tco DNA polymerase; Lane M shows protein molecular weight Marker;
- Figure 2 shows the results of Tco DNA polymerase amplifying nucleic acid fragments of different lengths; wherein, Lane M shows DNA molecular weight Marker; Lane 1 shows human genome 800 bp ⁇ -Actin fragment; Lane 2 shows human genome 1.3 kb ⁇ -globin fragment; Lane 3 shows Genomic 1.5kb ⁇ -globin tablets Segment; lane 4 shows the human genomic 3.0 kb ⁇ -globin fragment; lane 5 shows the 4.1 kb ⁇ -globin fragment; lane 6 shows the ⁇ genome 8 kb fragment;
- Figure 3 shows the results of Tco DNA polymerase and Pfo DNA polymerase amplifying high GC content nucleic acid template and inhibitor template; among them, 1 ⁇ 4 shows Tco DNA polymerase amplification results; a ⁇ d shows Pfu DNA polymerase expansion Increased results; Lane M shows DNA molecular weight Marker; Lane 1 shows 237 bp fragment of human whole blood; Lane 2 shows 1.5 kb 16 srDNA fragment of E. coli; Lane 3 shows 2 kb fragment of Thermus thermophilus HB8 gene; Lane 4 shows 1.5 kb fragment of human genome; Lane a A full-blood 237 bp fragment is shown; lane b shows a 1.5 kb 16 sr DNA fragment of E. coli; lane c shows a 2 kb fragment of Thermus thermophilus HB8 gene; and lane d shows a human genomic 1.5 kb fragment;
- Figure 4 shows the results of amplification of different template amounts of pUC19 plasmid by Tco DNA polymerase and Pfu DNA polymerase; 1 to 5 shows Tco DNA polymerase amplification results; 6 to 10 shows Pfli DNA polymerase amplification results; lane M DNA molecular marker Marker; Lane 1 shows 10 ng of pUC19; Yongdao 2 shows lng of pUC19; Yongdao 3 shows 0.1 ng of pUC19; Yongdao 4 shows O.Olng of pUC19; Lane 5 shows O.OOlng of pUC19 Lane 6 shows 10 ng of pUC19; lane ⁇ shows lng of pUC19; Lane 8 shows O. lng of pUC19; Lane 9 shows O.Olng of pUC19; Lane 10 shows O.OOlng of pUC19;
- Figure 5 shows the results of Tco DNA polymerase and Pfu DNA polymerase amplifying different templating amounts of human genomic DNA; wherein 1-4 shows Tco DNA polymerase amplification results; 5-8 shows Pfu DNA polymerase amplification results; M shows DNA molecular weight Marker; Lane 1 shows 25 ng of the human genome 1.3 kb fragment; Lane 2 shows 10 ng of the human genome 1.3 kb fragment; Lane 3 shows 5 ng of the human genome 1.3 kb fragment; Lane 4 shows 1 ng of the human genome 1.3 kb fragment; Lane 5 shows 25 ng of the human genome 1.3 kb fragment; Lane 6 shows 10 ng of the human genome 1.3 kb fragment; Lane 7 shows 5 ng of the human genome 1.3 kb fragment; Lane 8 shows 1 ng of the human genome 1.3 kb fragment; Figure 6 shows different DNA aggregation Enzyme amplification error rate; wherein 1 shows Taq DNA polymerase; 2 shows Pfu DNA polymerase; 3 shows Tco DNA
- the invention discloses a high-fidelity DNA polymerase, Tco DNA polymerase, and a preparation method of the high-fidelity DNA polymerase and application thereof in nucleic acid amplification.
- Those skilled in the art can refer to the content herein to obtain the high-fidelity DNA polymerase, and realize its application. It should be particularly noted that all similar substitutions and modifications will be apparent to those skilled in the art, and they are all regarded as It is included in the present invention.
- the preparation method and application of the present invention have been described in the preferred embodiments, and it is obvious that those skilled in the art can make modifications or appropriate changes and combinations to the preparation methods and applications herein without departing from the scope of the invention. The technique of the present invention is applied.
- the high fidelity DNA polymerase provided by the present invention and the reagents and materials used in the preparation and use thereof are commercially available.
- Example 1 Acquisition of DNA molecules encoding Tco DNA polymerase
- Thermococcus coalescens purchased from the Sakamoto Biological Collection, is JCM: 12540. The purchased strain was centrifuged at 12,000 rpm for 5 min, and the supernatant was discarded. The pellet was precipitated and the genomic DNA was extracted with reference to Promega's Wizard® Genomic DNA Purification kit. The brief steps are as follows:
- the cell pellet was resuspended in 600 ⁇ Nuclei Lysis Solution, and the cells were lysed in a water bath at 80 ° C for 5 min. After cooling to room temperature, add 20 ( ⁇ L Protein Preciptitation Solution, shake and mix, ice bath for 5 min; centrifuge at 12000 rpm for 5 min; absorb the supernatant to another A clean centrifuge tube, add 600 ⁇ isopropyl alcohol, mix and freeze in ice bath for 10 min; centrifuge at 12000 rpm for 5 min; nucleic acid precipitation is washed twice with 700 ⁇ 70% ethanol, centrifuged at 12000 rpm for 5 min, the supernatant is discarded, and the nucleic acid precipitate is dried at room temperature for 10 min. To the taste of no alcohol, add 50 ⁇ ⁇ to dissolve, and obtain the genomic DNA of the strain.
- the obtained Thermococcus coalescens genomic DNA was not subjected to whole genome sequencing, and thus the gene sequence of its DNA polymerase could not be obtained.
- BLAST similarity analysis the regions with high similarity of DNA polymerase sequences of the same sequence were obtained, and the primers were designed to obtain the Tco DNA polymerase coding sequence.
- the long gene and its upstream and downstream lkb nucleotide sequences were designed using the Clustal W software to compare the Thermococcus gammatolerans EJ3, Pyrococcus yayanosii CHI, Thermococcus kodakarensis KOD1, Thermococcus onnurineus NA1, Thermococcus sibiricus MM 739 sequence ⁇ 1 J , and designed primers:
- Primer BamHITcoF having the nucleotide sequence as shown in SEQ ID NO: 5;
- Primer Tco493R having the nucleotide sequence as shown in SEQ ID NO: 6;
- Primer Tco3085F having the nucleotide sequence as shown in SEQ ID NO: 7; primer TcoDownR: having the nucleotide sequence as shown in SEQ ID NO: 8;
- the PCR reaction solution was prepared according to the following system: 5 ( ⁇ L system contains: 50 ng of the above genomic DNA, 400 nmol/L of primers, dNTPs 20 ( ⁇ mol/L, 5 x Prime STAR® Buffer ( Mg 2+ plus ) 1 ⁇ , BioScience's PrimeSTAR®HS 0.5 ⁇ PCR amplification procedure: 98 °C 2min, (94 °C 10s; 55 °C 20s; 68 °C 3min) 25 cycles, extension at 68 °C for 5 min.
- the nucleotide sequence obtained by the above sequencing was confirmed by NCBI to be the most similar to the DNA polymerase B gene of Thermococcus and Pyrococcus, and the similarity with Thermococcus sp. AM4 DNA polymerase B was 79%. What is obtained is the coding sequence of Tco DNA polymerase. Analysis of the sequence revealed that the encoded DNA polymerase contained an intein, and the two amplified sequences could not be spliced into a full-length gene.
- Primer Tco30F having the nucleotide sequence as shown in SEQ ID NO: 9;
- the extracted genomic DNA was used as a template, and a fragment of about 3.5 kb was amplified and constructed into a pGM-T vector, which was sequenced. The sequence was also found to contain intein. According to the sequencing result, the 3.5 kb fragment was spliced with a fragment of about 2.5 kb amplified by the primer BamHITcoF+Tco493R to obtain Tco DNA polymerase.
- the full-length gene has a full sequence comprising 6186 bp, the sequence of which is shown in SEQ ID NO: 3, and the encoded protein is 2061 aa, and the amino acid sequence thereof is shown in SEQ ID NO: 4.
- the Tco DNA polymerase gene was divided into four coding frames by three inteins, and the gene including 2328 bp was removed after the intein was removed.
- the encoded mature protein is 775 aa.
- Primer Tcol2R having the nucleotide sequence as shown in SEQ ID NO: 10;
- Primer TcoORF12F having the nucleotide sequence shown as SEQ ID NO: 1 1
- primer NTcoORF2R having the nucleotide sequence shown as SEQ ID NO: 12
- primer NTcoORF23F having the sequence shown in SEQ ID NO: 13.
- Nucleotide sequence; primer TcoORF3R having the nucleotide sequence shown as SEQ ID NO: 14;
- Primer NTcoORF34F having the nucleotide sequence shown as SEQ ID NO: 15; primer NotlTcoWR: having the nucleotide sequence shown as SEQ ID NO: 16; using the extracted genomic DNA as a template, PrimeSTAR amplification
- BamfflTcoF and Tcol2R were amplified to obtain about 1.2 kb of ORF1
- TcoORF12F and NTcoORF2R were amplified to obtain about 250 bp of ORF2
- NTcoORF23F and TcoORF3R were amplified to obtain about 150 bp of ORF3R
- NTcoORF34F and NotlTcoWR were amplified to obtain about 700 bp of ORF4.
- the four ORFs were ligated to the pGM-T vector, sequenced and aligned with the spliced full-length gene, and the results showed - corresponding.
- the target fragment of about 2.3 kb in length obtained in Example 1 was digested with BamH I and Not I, ligated into the same digested T7 promoter-containing vector, and transformed into DH5a competent form. In the cell.
- IPTG was added to its final concentration of 0.1 mmol/L, and induced at 30 °C for 4 h; the induced bacterial solution was collected, centrifuged at 12,000 rpm for 2 min, the supernatant was discarded, and the cells were pH 7.8 with 20 mL/20 mmol/L Tris- HCl, O.lmol/L KCl, 50mmol/L NaCl buffer A plus 30mmol/L imidazole resuspended, frozen in -80°C refrigerator for 12h; 37°C lysed cells, ultrasonically disrupted at 70°C water bath After treatment for 30 min, centrifuge at 12000 rpm for 10 min; the supernatant was purchased from the National Biochemical Engineering Technology Research Center and eluted with buffer A containing 400 mmol/L imidazole; the eluate was purchased from the National Biochemical Engineering Technology Research Center.
- the affinity medium was eluted with buffer A containing 200 mmol/L, 400 mmol/L, 600 mmol/L, and 1 mol/L NaCl; each protein peak was collected and detected by SDS-PAGE, and buffer A containing 200 mmol/L NaCl was found.
- a part of the target protein can be eluted, buffer A containing 400 mmol/L NaCl is eluted with a large amount of the target protein, and the obtained product is dialyzed to Storage buffer: pH 7.4, 20 mmol/L Tris-HCl, 0.1 mmol/L EDTA, 0.1% Tween 20, 0.5% Nonidet P40, Ol mol/L KCl, 50% glycerol.
- Tco DNA polymerase was successfully obtained.
- SDS-PAGE showed the purification results as shown in Figure 1: Lane 1 shows purified Tco DNA polymerase; Lane M shows the molecular weight of the marker, Marker.
- the obtained Tco DNA polymerase has a molecular weight of about 90 kDa, which is consistent with its theoretical size, and its purity is more than 95% by BandScan software.
- Example 5 Determination of Tco DNA Polymerase Activity
- the Tco DNA polymerase prepared in Example 4 was assayed for its activity at a nucleotide concentration of 30 min at 72 ° C, diluted to 2.5 uL, and tested for its 3,-5, exonuclease activity by fluorescent probe method. The results showed that Tco DNA polymerase had strong corrective activity, indicating that its amplification fidelity performance was better.
- the enzyme was incubated at 90 ° C, and the DNA polymerase activity was measured at 0, 1, 2, 3, 4, 5, 6 h. The results showed that Tco DNA polymerase had a pole. High thermal stability with a 90°C half-life of 6 h.
- the Tco DNA polymerase prepared in Example 4 was applied to nucleic acid amplification. First, the reaction conditions of the Tco DNA polymerase in nucleic acid amplification were tested. Using pUC19 plasmid as a template, primers were designed to amplify about 2.7 kb fragment to determine the optimum pH value of the reaction and K + , NH 4 + , Mg 2 . + ion concentration.
- the optimal reaction conditions for determining Tco DNA polymerase were 10 X Tco buffer: pH 8.4, 500 mmol/L Tris-HCl, 150 mmol/L KC1, 100 mmol/L (NH 4 ) 2 S0 4 , 15 mmol/L MgCl 2 .
- the 10 x Tco buffer and the Tco DNA polymerase prepared in Example 4 were respectively Amplification: Human genomic DNA of about 800 bp P-Actin, 1.3 kb, 1.5 kb, 3.0 kb, and 4.1 kb ⁇ -globin fragments and ⁇ genome of 8 kb fragment, agarose gel electrophoresis results showed that they were well amplified. Target segment.
- Thermus thermophilus HB8 genome has a GC content of about 70%. It is difficult to amplify such a template for ordinary PCR reactions. However, some templates are susceptible to contamination by inhibitors in the material source during the purification process, resulting in failure of the PCR reaction, such as Anticoagulant EDTA, heparin, etc. in the blood.
- a 237 bp SOX21 non-coding fragment was directly PCR amplified using human whole blood containing EDTA as a template; Approximately 1.5 kb fragment of 16srDNA was amplified by Bacillus lysate as a template; the high-GC fragment of about 2 kb was amplified with the Thermus thermophilus HB8 genome as a template, and its GC content was about 72%.
- the human genome was used as a template to amplify it to a height of about 1.5 kb.
- the GC fragment has a GC content of about 65.9%.
- the Pfo DNA polymerase purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. is used as a comparative solution, and is amplified according to the optimum conditions. After the reaction is completed, the same amount of product is electrophoresed. . Tco DNA polymerase can be well amplified to obtain the desired band, while the comparative example has no target band. As a result of agarose gel electrophoresis, the results are shown in Figure 3.
- the 2.7 kb pUC19 plasmid was amplified using the Tco DNA polymerase prepared in Example 4. 10 ng, lng, 0.1 ng, O.Olng, 0.00 lng UC19 plasmid, 5 ( ⁇ L reaction system, Tco DNA polymerase prepared in Example 4 and Pfu purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. DNA polymerase was amplified according to the optimal conditions. After the reaction was completed, 5 ⁇ product electrophoresis was detected. The results of agarose gel electrophoresis showed that the amplification sensitivity of Tco DNA polymerase was much higher than that of Pfu DNA polymerase.
- 1 to 5 shows Tco DNA polymerase amplification results; 6-10 shows Pfli DNA polymerase amplification results; Lane M shows DNA molecular weight Marker; Lane 1 shows 10 ng of pUC19; Lane 2 shows lng of pUC19; Lane 3 O. lng pUC19; Lane 4 shows O.Ongng pUC19; Lane 5 shows O.OOlng of pUC19; Lane 6 shows 10 ng of pUC19; Lane 7 shows lng of pUC19; Lane 8 shows O. lng of pUC19; Lane 9 O.Olng pUC19; Lane 10 shows O.OOlng pUC19.
- Tco DNA polymerase can detect O.Olng pUC19 plasmid, while Pfu DNA polymerase Amplify this only under 10 ng conditions The tablets.
- Example 9 different amounts of template ⁇ ⁇ , Tco DNA polymerase amplification activity
- the human 1.3 kb fragment was amplified using the Tco DNA polymerase prepared in Example 4. 25g, 10ng, 5ng, lng of human genomic DNA, 50 ⁇ reaction system, Tco DNA polymerase prepared in Example 4 and Pfu DNA polymerase purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. Conditional amplification, after completion of the reaction, 5 L product electrophoresis was detected. Agarose gel electrophoresis results showed that the amplification sensitivity of Tco DNA polymerase was much higher than that of Pfo DNA polymerase.
- the fidelity of the Tco DNA polymerase prepared in Example 4 was tested by the method of blue-white spot, and the full-length plasmid was amplified by using TUC DNA polymerase, Taq DNA polymerase and Pfu DNA polymerase, respectively, using the pUC19 plasmid as a template. Amplification factor of each enzyme.
- the fidelity of DNA polymerase was 1/ER, and the lower the error rate, the better the fidelity.
- the results showed that Tco DNA polymerase had good fidelity performance, and its fidelity was 1.8 times that of Pfu and 9.2 times that of Taq.
- Figure 6 shows the error rate of the three, where 1 shows Taq DNA polymerase; 2 shows Pfli DNA polymerase; 3 shows Tco DNA polymerase.
- the error rate of Tco DNA polymerase is: 1.2 ⁇ 1 ⁇
- the error rate of Pfo DNA polymerase is: 2.2 10" 6
- the error rate of Taq DNA polymerase is: 10.9 10" 6
- the fidelity of Tco DNA polymerase is 1.8 times that of Pfu DNA polymerase and 9.2 times that of Taq DNA polymerase.
- Polymerase which has the ability to amplify different templates and fragments, and also has good results for complex templates and inhibitor-containing templates, and has high fidelity amplification ability, suitable for all kinds of PCR and requirements for amplification fidelity. High experiments are also suitable as high-fidelity DNA polymerases in PCR amplification kits.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
一种高保真 DNA聚合酵及其制备和应用 High-fidelity DNA polymerase and preparation and application thereof
本申请要求于 2013 年 06 月 28 日提交中国专利局、 申请号为 201310268966.9、发明名称为 "一种高保真 DNA聚合酶及其制备和应用" 的中国专利申请的优先权, 其全部内容通过引用结合在本申请中。 技术领域 This application claims priority to Chinese Patent Application No. 201310268966.9, entitled "A High-Fidelity DNA Polymerase and Its Preparation and Application", filed on June 28, 2013, the entire contents of which is hereby incorporated by reference. Combined in this application. Technical field
本发明属于基因工程领域, 涉及一种高保真 DNA聚合酶及其制备和 应用。 背景技术 The invention belongs to the field of genetic engineering and relates to a high fidelity DNA polymerase and its preparation and application. Background technique
DNA聚合酶广泛应用于分子生物学研究中, 如 DNA测序、 标记、 突变和核酸扩增等反应。 耐热 DNA聚合酶由于其热稳定性, 在核酸高温 变性的条件下不会失活, 是目前核酸扩增的常用酶。 根据序列的不同, DNA聚合酶可以分为六大族: A、 B、 C、 D、 X和 Y, 耐热 DNA聚合酶 主要属于 A族和 B族, 并具有相似的生物学性质。 A族 DNA聚合酶的 代表是 Taq DNA聚合酶,该聚合酶分离自 The醒 s aquaticus YT-1的基因 组, 具有 5,-3,的 DNA外切酶活性和 5,-3,DNA聚合酶活性, 其菌株生长 于 75 °C左右的温泉中, 由于其能耐受高温变性, 自发现后被广泛应用于 PCR反应, 目前已被开发成多种试剂盒; 后来的研究又从其他物种中分 离出了多种 A族 DNA聚合酶, 但由于其不具有 3,-5,的外切酶校正活性, 容易在扩增时掺入错误的碱基,导致不能忠实地扩增模板,直到 B族 DNA 聚合酶的发现, 才使得高保真地扩增模板成为可能。 B族 DNA聚合酶主 要分离自古细菌, 包括广古菌、 泉古菌、 纳古菌和初古菌, 其具有更高的 热稳定性, 同时其 3,-5,外切酶校正活性能识别错误掺入延伸链中的碱基, 并将其切下, 利用 DNA聚合酶活性添加为与模板互补的碱基, 从而保证 了新扩增链与模板的高度一致性。 DNA polymerases are widely used in molecular biology research, such as DNA sequencing, labeling, mutation, and nucleic acid amplification. Heat-resistant DNA polymerase is not attenuated under the conditions of high temperature denaturation of nucleic acid due to its thermal stability, and is a commonly used enzyme for nucleic acid amplification. Depending on the sequence, DNA polymerase can be divided into six major groups: A, B, C, D, X and Y. The heat-resistant DNA polymerase mainly belongs to group A and group B, and has similar biological properties. Representative of the A-group DNA polymerase is Taq DNA polymerase, which is isolated from the genome of The s aquaticus YT-1, having 5,-3, exonuclease activity and 5,-3, DNA polymerase activity. Its strain is grown in hot springs around 75 °C. Because it can withstand high temperature denaturation, it has been widely used in PCR since its discovery. It has been developed into a variety of kits; later studies have been isolated from other species. A variety of Group A DNA polymerases have emerged, but because they do not have the exonuclease-correcting activity of 3,-5, it is easy to incorporate the wrong base during amplification, resulting in the inability to faithfully amplify the template until the B group. The discovery of DNA polymerases made it possible to amplify templates with high fidelity. The B-group DNA polymerase is mainly isolated from archaea, including the archaea, the archaea, the cyanobacteria and the archaea, which have higher thermal stability, and the 3,-5, exonuclease-correcting activity can be recognized. The bases in the extended strand are incorrectly incorporated, and they are excised, and the DNA polymerase activity is added as a base complementary to the template, thereby ensuring high consistency between the newly amplified strand and the template.
超嗜热古菌具有严格厌氧和超嗜热生长的特性, 如 PyrocHciium和 ^awc^ym?属的物种能在 1 10°C生长, 而低于 80°C则不能生长; 从大西 洋中脊 3650米的超热烟囱中分离的 >Ofob^/M an7是目前已知最耐热的 古菌, 其能在高达 113°C的高温条件下增值, 而低于 90°C则停止生长。 目 前已经从 OCOCO«和 7¾er ococo«属中分离出了许多 DNA聚合酶, 某些 DNA聚合酶在极高的温度下仍能保持稳定, 被应用于分子生物学研究, 尤其是核酸扩增中。 其中, Pfo DNA聚合酶是一种来源于 ^racoco^ /Mn'om?的热稳定的 DNA聚合酶,具有 5,-3, DNA聚合酶活性和 3,-5,的外切 酶活性。 由于 Pfu DNA聚合酶有 3,-5,的外切酶活性, 因此在核酸扩增过程 中出错的机率大大降低, 保真性约为 Taq DNA聚合酶的 6倍。 目前, Pfo DNA聚合酶通常作为首选的高保真 DNA聚合酶,用于核酸的高保真扩增, 但是, 在实际应用过程中, Pfo DNA聚合酶对引物和样品的结构、 纯度和 浓度要求比较高, 反应灵敏度较低, 扩增效率较低, 限制了 Pfu DNA聚合 酶的使用和推广。 发明内容 Hyperthermophilic archaea has strict anaerobic and hyperthermophilic growth characteristics, such as PyrocHciium and ^awc^ym? species can grow at 10 ° C, but below 80 ° C can not grow; from Daxi >Ofob^/M an7 isolated from the 3650 m superheated chimney of the mid-ocean ridge is the most heat-resistant archaea known at present, which can be increased at high temperatures up to 113 ° C, and stopped below 90 ° C. Growing. Many DNA polymerases have been isolated from the OCOCO« and 73⁄4er ococo« genus. Some DNA polymerases remain stable at very high temperatures and are used in molecular biology research, especially in nucleic acid amplification. Among them, Pfo DNA polymerase is a thermostable DNA polymerase derived from ^racoco^/Mn'om?, having 5,-3, DNA polymerase activity and exonuclease activity of 3,-5. Since Pfu DNA polymerase has exonuclease activity of 3,-5, the probability of error in nucleic acid amplification is greatly reduced, and the fidelity is about 6 times that of Taq DNA polymerase. At present, Pfo DNA polymerase is usually used as the preferred high-fidelity DNA polymerase for high-fidelity amplification of nucleic acids. However, in practical applications, Pfo DNA polymerase requires high structure, purity and concentration of primers and samples. The reaction sensitivity is low and the amplification efficiency is low, which limits the use and promotion of Pfu DNA polymerase. Summary of the invention
有鉴于此,本发明的目的在于提供一种高灵敏度、 高扩增效率的高保 真 DNA聚合酶及其制备和应用。 In view of the above, an object of the present invention is to provide a high-sensitivity, high-amplification high-fidelity DNA polymerase, and its preparation and use.
为了实现本发明的目的, 本发明釆用如下的技术方案: In order to achieve the object of the present invention, the present invention uses the following technical solutions:
本发明提供了一种高保真 DNA聚合酶, 命名为 Tco DNA聚合酶, 其具有(1 )、 (II )所示的氨基酸序列中任意一个: The present invention provides a high-fidelity DNA polymerase, designated Tco DNA polymerase, having any one of the amino acid sequences shown in (1), (II):
( I ) 具有 SEQ ID NO: 1所示的氨基酸序列; (I) having the amino acid sequence of SEQ ID NO: 1;
( II ) 具有 SEQ ID NO:l所示的氨基酸序列经取代、 缺失或添加一个 或多个氨基酸获得的氨基酸序列。 (II) An amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
本发明提供了一种 Tco DNA聚合酶在核酸扩增中的应用, Tco DNA 聚合酶具有(I )、 (II )所示的氨基酸序列中任意一个: The invention provides a Tco DNA polymerase for use in nucleic acid amplification, and the Tco DNA polymerase has any one of the amino acid sequences shown by (I) and (II):
( I ) 具有 SEQ ID NO: 1所示的氨基酸序列; (I) having the amino acid sequence of SEQ ID NO: 1;
( II ) 具有 SEQ ID NO:l所示的氨基酸序列经取代、 缺失或添加一个 或多个氨基酸获得的氨基酸序列。 (II) An amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
本发明提供了一种编码 Tco DNA聚合酶的 DNA分子, 其具有 I、 II所示的核苷酸序列中任意一个: The present invention provides a DNA molecule encoding Tco DNA polymerase, which has I, Any one of the nucleotide sequences shown in II:
I 具有 SEQ ID NO:2所示的核苷酸序列; I has the nucleotide sequence shown in SEQ ID NO: 2;
II 具有 SEQIDNO:2所示的核苷酸序列经取代、缺失或添加一个或 多个碱基获得的核苷酸序列; a nucleotide sequence obtained by substituting, deleting or adding one or more bases of the nucleotide sequence shown by SEQ ID NO: 2;
TcoDNA聚合酶具有(1)、 (II)所示的氨基酸序列中任意一个: TcoDNA polymerase has any one of the amino acid sequences shown in (1) and (II):
( I ) 具有 SEQIDNO:l所示的氨基酸序列; (I) having the amino acid sequence shown by SEQ ID NO:1;
(II) 具有 SEQ IDNO:l所示的氨基酸序列经取代、 缺失或添加一个 或多个氨基酸获得的氨基酸序列。 (II) An amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
本发明提供了一种重组载体, 其含有编码 Tco DNA聚合酶的 DNA 分子, 该 DNA分子具有具有 I、 II所示的核苷酸序列中任意一个: I 具有 SEQ ID NO:2所示的核苷酸序列; The present invention provides a recombinant vector comprising a DNA molecule encoding a Tco DNA polymerase having any one of the nucleotide sequences represented by I and II: I having the core represented by SEQ ID NO: Glycosidic acid sequence;
II 具有 SEQIDNO:2所示的核苷酸序列经取代、缺失或添加一个或 多个碱基获得的核苷酸序列; a nucleotide sequence obtained by substituting, deleting or adding one or more bases of the nucleotide sequence shown by SEQ ID NO: 2;
Tco DNA聚合酶具有( I )、 (II )所示的氨基酸序列中任意一个: ( I ) 具有 SEQ ID NO: 1所示的氨基酸序列; The Tco DNA polymerase has any one of the amino acid sequences shown in (I) and (II): (I) having the amino acid sequence of SEQ ID NO: 1;
(II) 具有 SEQ IDNO:l所示的氨基酸序列经取代、 缺失或添加一个 或多个氨基酸获得的氨基酸序列。 (II) An amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
优选地, 上述的重组载体为含有 T7启动子的重组载体。 Preferably, the above recombinant vector is a recombinant vector containing a T7 promoter.
本发明提供了一种 PCR扩增试剂盒, 其含有 Tco DNA聚合酶, 该 TcoDNA聚合酶具有(1)、 (II)所示的氨基酸序列中任意一个: The present invention provides a PCR amplification kit comprising Tco DNA polymerase having any one of the amino acid sequences shown in (1) and (II):
( I ) 具有 SEQIDNO:l所示的氨基酸序列; (I) having the amino acid sequence shown by SEQ ID NO:1;
(II) 具有 SEQ IDNO:l所示的氨基酸序列经取代、 缺失或添加一个 或多个氨基酸获得的氨基酸序列。 (II) An amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
本发明还提供一种高保真 DNA聚合酶的制备方法, 包括以下步骤: 获得具有编码如( I )或( II )所限定的氨基酸序列的 DNA分子; 取上述 DNA分子与表达载体融合, 构建重组表达载体; The present invention also provides a method for preparing a high-fidelity DNA polymerase, comprising the steps of: obtaining a DNA molecule having an amino acid sequence encoding as defined in (I) or (II); and merging the above DNA molecule with an expression vector to construct a recombinant Expression vector;
取上述重组表达载体转入宿主细胞, 获得转化体; Transferring the above recombinant expression vector into a host cell to obtain a transformant;
诱导上述转化体表达融合蛋白, 经分离纯化, 获得高保真 DNA聚合 酶; Inducing the above transformant to express the fusion protein, and separating and purifying to obtain high fidelity DNA polymerization Enzyme
( I )为: 具有 SEQ ID NO: 1所示的氨基酸序列; (I) is: having the amino acid sequence of SEQ ID NO: 1;
(Π)为: 具有 SEQIDNO:l所示的氨基酸序列经取代、 缺失或添加一 个或多个氨基酸获得的氨基酸序列。 (Π) is: an amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
优选地,具有编码如( I )或( II )所限定的氨基酸序列的 DNA分子,具 体为具有 I、 II所示的核苷酸序列中任意一个: Preferably, the DNA molecule having an amino acid sequence as defined in (I) or (II), specifically having any one of the nucleotide sequences shown by I, II:
I 具有 SEQ ID NO:2所示的核苷酸序列; I has the nucleotide sequence shown in SEQ ID NO: 2;
II 具有 SEQ ID NO:2所示的核苷酸序列经取代、 缺失或添加一个或 多个碱基获得的核苷酸序列。 II A nucleotide sequence obtained by substituting, deleting or adding one or more bases of the nucleotide sequence shown by SEQ ID NO: 2.
优选地, 获得具有编码如(I )或(II)所限定的氨基酸序列的 DNA分 子, 具体为从超嗜热古菌 Thermococcus coalescens 分萬、重组构建出上 述的 DNA分子; 上述的超嗜热古菌购自日本微生物菌种保藏中心, 其保 藏编号为 JCM:12540, 其分离自伊豆小笠原海沟水耀海山的超高温海水 中, 为 0.5-2μΜ的不规则球形, 在指数生长期时, 能融合为约 5μΜ的融 合细胞; 该细菌生长于 57-90°C, pH值为 5.2-8.7, 其最适 pH值为 6.5, 最佳生长温度为 87°C, 具有超强嗜热生长特性; Preferably, a DNA molecule having an amino acid sequence encoding as defined in (I) or (II) is obtained, specifically, the above DNA molecule is recombinantly constructed from the hyperthermophilic archaea Thermococcus coalescens; the above hyperthermophilic ancient The fungus was purchased from the Japan Collection of Microorganisms and Cultures, and its deposit number is JCM: 12540. It is isolated from the ultra-high temperature seawater of the Shuiyuanhai Mountain of the Izu Ogasawara, and it is an irregular spherical shape of 0.5-2 μΜ. It can be fused during the exponential growth phase. It is a fusion cell of about 5 μΜ; the bacteria is grown at 57-90 ° C, pH 5.2-8.7, its optimum pH is 6.5, and the optimal growth temperature is 87 ° C, which has super thermophilic growth characteristics;
( I )为: 具有 SEQ ID NO: 1所示的氨基酸序列; (I) is: having the amino acid sequence of SEQ ID NO: 1;
(Π)为: 具有 SEQIDNO:l所示的氨基酸序列经取代、 缺失或添加一 个或多个氨基酸获得的氨基酸序列。 (Π) is: an amino acid sequence obtained by substituting, deleting or adding one or more amino acids of the amino acid sequence shown by SEQ ID NO: 1.
优选地, 一种高保真 DNA聚合酶的制备方法中所用到的宿主细胞, 为原核系统宿主细胞。 Preferably, the host cell used in the preparation method of the high fidelity DNA polymerase is a prokaryotic system host cell.
优选地, 一种高保真 DNA聚合酶的制备方法中所用到的宿主细胞, 为大肠杆菌宿主细胞。 Preferably, the host cell used in the preparation method of the high fidelity DNA polymerase is an E. coli host cell.
优选地,一种高保真 DNA聚合酶的制备方法中的纯化操作,具体为, 釆用凝胶介质纯化。 Preferably, the purification operation in a method for preparing a high-fidelity DNA polymerase, specifically, purification using a gel medium.
在本发明的一些实施例中, 一种制备 Tco DNA聚合酶的方法, 具体 为: In some embodiments of the invention, a method of making Tco DNA polymerase is specifically:
( 1 )通过同源比对 Thermococcus属不同 DNA聚合酶基因核苷酸序 歹 'J , 以相似性较高的区段设计引物, 扩增 Thermococcus coalescens DNA 聚合酶基因片段,再根据得到的序列信息,不断扩增得到基因的全长序列 如 SEQ ID NO:3所示的核苷酸序列; (1) Nucleotide sequence of different DNA polymerase genes by the homologous ratio of Thermococcus 歹'J, designing primers with higher similarity segments, amplifying the Thermococcus coalescens DNA polymerase gene fragment, and then continuously amplifying the full-length sequence of the gene according to the obtained sequence information as shown in SEQ ID NO: Nucleotide sequence;
( 2 )分析上述基因结构, 扩增成熟蛋白编码序列, 通过重叠 PCR得 到如 SEQ ID NO:2所示的基因片段, 构建至含 T7启动子的载体上, 得到 重组载体; (2) analyzing the above gene structure, amplifying the mature protein coding sequence, and obtaining a gene fragment as shown in SEQ ID NO: 2 by overlapping PCR, and constructing the vector into the vector containing the T7 promoter to obtain a recombinant vector;
( 3 )将上述重组载体转化至宿主细胞 E.coli Rosetta(DE3)中,得到能 生产该高保真 DNA聚合酶的转化体; (3) transforming the above recombinant vector into a host cell E. coli Rosetta (DE3) to obtain a transformant capable of producing the high-fidelity DNA polymerase;
( 4 )扩大培养该转化体, 诱导后用于制备该高保真 DNA聚合酶; ( 5 ) 利用镍凝胶介质和肝素层析柱依次纯化, 获得该高保真 DNA 聚合酶。 (4) The transformant is expanded and used to prepare the high-fidelity DNA polymerase after induction; (5) the high-fidelity DNA polymerase is obtained by sequentially purifying using a nickel gel medium and a heparin chromatography column.
本发明提供了一种高保真 DNA聚合酶及其制备方法和在核酸扩增中 的应用。 该高保真 DNA聚合酶具有 SEQ ID ΝΟ: 1所示的氨基酸序列, 或 者 SEQ ID ΝΟ: 1所示的氨基酸序列经取代、 缺失或添加一个或多个氨基 酸获得的氨基酸序列。 实验数据表明,釆用本发明所公布的制备方法所制 备得的高保真 DNA聚合酶的纯度达 95%以上, 与 Pfu高保真 DNA聚合 酶相比, 本发明提供的高保真 DNA聚合酶能够扩增高 GC含量的核酸模 板、 样品纯度较低的核酸模板, 同时, 也能实现对极低的模板量的扩增, 大幅提高了高保真 DNA聚合酶的灵敏度和扩增效率, 同时具有较高的保 真性, 适合各类 PCR及对扩增保真性要求较高的实验, 也适合作为 PCR 扩增试剂盒中的高保真 DNA聚合酶。 附图说明 The present invention provides a high fidelity DNA polymerase, a preparation method thereof and use in nucleic acid amplification. The high-fidelity DNA polymerase has the amino acid sequence shown in SEQ ID NO: 1, or the amino acid sequence obtained by substituting, deleting or adding one or more amino acids to the amino acid sequence shown in SEQ ID NO: 1. The experimental data show that the purity of the high-fidelity DNA polymerase prepared by the preparation method disclosed in the present invention is over 95%, and the high-fidelity DNA polymerase provided by the present invention can be expanded compared with the Pfu high-fidelity DNA polymerase. Increased GC content of nucleic acid template, nucleic acid template with low sample purity, and also can achieve very low template amount amplification, greatly improving the sensitivity and amplification efficiency of high-fidelity DNA polymerase, while having a higher The fidelity is suitable for all kinds of PCR and experiments with high requirements for amplification fidelity, and is also suitable as a high-fidelity DNA polymerase in a PCR amplification kit. DRAWINGS
图 1示 Tco DNA聚合酶的纯化结果;其中,泳道 1示纯化的 Tco DNA 聚合酶; 泳道 M示蛋白分子量 Marker; Figure 1 shows the results of purification of Tco DNA polymerase; wherein Lane 1 shows purified Tco DNA polymerase; Lane M shows protein molecular weight Marker;
图 2示 Tco DNA聚合酶扩增不同长度的核酸片段的结果; 其中, 泳 道 M示 DNA分子量 Marker; 泳道 1示人基因组 800bp β-Actin片段; 泳 道 2示人基因组 1.3kb β-globin片段;泳道 3示人基因组 1.5kb β-globin片 段;泳道 4示人基因组 3.0kb β-globin片段;泳道 5示 4.1kb β-globin片段; 泳道 6示 λ基因组 8kb片段; Figure 2 shows the results of Tco DNA polymerase amplifying nucleic acid fragments of different lengths; wherein, Lane M shows DNA molecular weight Marker; Lane 1 shows human genome 800 bp β-Actin fragment; Lane 2 shows human genome 1.3 kb β-globin fragment; Lane 3 shows Genomic 1.5kb β-globin tablets Segment; lane 4 shows the human genomic 3.0 kb β-globin fragment; lane 5 shows the 4.1 kb β-globin fragment; lane 6 shows the λ genome 8 kb fragment;
图 3示 Tco DNA聚合酶和 Pfo DNA聚合酶扩增高 GC含量核酸模板 和含抑制剂模板的结果; 其中, 1 ~ 4示 Tco DNA聚合酶扩增结果; a ~ d 示 Pfu DNA聚合酶扩增结果; 泳道 M示 DNA分子量 Marker; 泳道 1示 人全血 237bp片段; 泳道 2示大肠杆菌菌液 1.5kb 16srDNA片段; 泳道 3 示 Thermus thermophilus HB8基因 2kb片段; 泳道 4示人基因组 1.5kb片 段; 泳道 a 示人全血扩增 237bp 片段; 泳道 b 示大肠杆菌菌液 1.5kb 16srDNA片段; 泳道 c示 Thermus thermophilus HB8基因 2kb片段; 泳道 d示人基因组 1.5kb片段; Figure 3 shows the results of Tco DNA polymerase and Pfo DNA polymerase amplifying high GC content nucleic acid template and inhibitor template; among them, 1 ~ 4 shows Tco DNA polymerase amplification results; a ~ d shows Pfu DNA polymerase expansion Increased results; Lane M shows DNA molecular weight Marker; Lane 1 shows 237 bp fragment of human whole blood; Lane 2 shows 1.5 kb 16 srDNA fragment of E. coli; Lane 3 shows 2 kb fragment of Thermus thermophilus HB8 gene; Lane 4 shows 1.5 kb fragment of human genome; Lane a A full-blood 237 bp fragment is shown; lane b shows a 1.5 kb 16 sr DNA fragment of E. coli; lane c shows a 2 kb fragment of Thermus thermophilus HB8 gene; and lane d shows a human genomic 1.5 kb fragment;
图 4示 Tco DNA聚合酶和 Pfu DNA聚合酶扩增不同模板量的 pUC19 质粒的结果; 其中 1 ~ 5示 Tco DNA聚合酶扩增结果; 6 ~ 10示 Pfli DNA 聚合酶扩增结果;泳道 M示 DNA分子量 Marker;泳道 1示 10ng的 pUC19; ;永道 2示 lng的 pUC19; ;永道 3示 0.1 ng的 pUC19; ;永道 4示 O.Olng的 pUC19; 泳道 5示 O.OOlng的 pUC19; 泳道 6示 10ng的 pUC19; 泳道 Ί 示 lng的 pUC19; 泳道 8示 O. lng的 pUC19; 泳道 9示 O.Olng的 pUC19; 泳道 10示 O.OOlng的 pUC19; Figure 4 shows the results of amplification of different template amounts of pUC19 plasmid by Tco DNA polymerase and Pfu DNA polymerase; 1 to 5 shows Tco DNA polymerase amplification results; 6 to 10 shows Pfli DNA polymerase amplification results; lane M DNA molecular marker Marker; Lane 1 shows 10 ng of pUC19; Yongdao 2 shows lng of pUC19; Yongdao 3 shows 0.1 ng of pUC19; Yongdao 4 shows O.Olng of pUC19; Lane 5 shows O.OOlng of pUC19 Lane 6 shows 10 ng of pUC19; lane Ί shows lng of pUC19; Lane 8 shows O. lng of pUC19; Lane 9 shows O.Olng of pUC19; Lane 10 shows O.OOlng of pUC19;
图 5示 Tco DNA聚合酶和 Pfu DNA聚合酶扩增不同模板量的人基因 组 DNA的结果;其中 1 ~ 4示 Tco DNA聚合酶扩增结果; 5 ~ 8示 Pfu DNA 聚合酶扩增结果; 泳道 M示 DNA分子量 Marker; 泳道 1示 25ng的人基 因组 1.3kb片段; 泳道 2示 10ng的人基因组 1.3kb片段; 泳道 3示 5ng 的人基因组 1.3kb片段; 泳道 4示 lng的人基因组 1.3kb片段; 泳道 5示 25ng的人基因组 1.3kb片段; 泳道 6示 10ng的人基因组 1.3kb片段; 泳 道 7示 5ng的人基因组 1.3kb片段;泳道 8示 lng的人基因组 1.3kb片段; 图 6示不同 DNA聚合酶扩增错误率; 其中 1示 Taq DNA聚合酶; 2 示 Pfu DNA聚合酶; 3示 Tco DNA聚合酶。 具体实施方式 本发明公开了一种高保真 DNA聚合酶, Tco DNA聚合酶, 以及所述 的高保真 DNA聚合酶的制备方法和在核酸扩增中的应用。 本领域技术人 员可以参考本文内容, 获得所述的高保真 DNA聚合酶, 实现其应用, 特 别需要指出的是,所有类似的替换和改动对本领域技术人员来说是显而易 见的,它们都被视为包括在本发明内。本发明的制备方法及应用已经通过 较佳的实施例进行了描述,相关人员明显能在不脱离本发明内容、精神和 范围内对本文制备方法和应用进行改动或适当变更与组合 ,来实现和应用 本发明技术。 Figure 5 shows the results of Tco DNA polymerase and Pfu DNA polymerase amplifying different templating amounts of human genomic DNA; wherein 1-4 shows Tco DNA polymerase amplification results; 5-8 shows Pfu DNA polymerase amplification results; M shows DNA molecular weight Marker; Lane 1 shows 25 ng of the human genome 1.3 kb fragment; Lane 2 shows 10 ng of the human genome 1.3 kb fragment; Lane 3 shows 5 ng of the human genome 1.3 kb fragment; Lane 4 shows 1 ng of the human genome 1.3 kb fragment; Lane 5 shows 25 ng of the human genome 1.3 kb fragment; Lane 6 shows 10 ng of the human genome 1.3 kb fragment; Lane 7 shows 5 ng of the human genome 1.3 kb fragment; Lane 8 shows 1 ng of the human genome 1.3 kb fragment; Figure 6 shows different DNA aggregation Enzyme amplification error rate; wherein 1 shows Taq DNA polymerase; 2 shows Pfu DNA polymerase; 3 shows Tco DNA polymerase. detailed description The invention discloses a high-fidelity DNA polymerase, Tco DNA polymerase, and a preparation method of the high-fidelity DNA polymerase and application thereof in nucleic acid amplification. Those skilled in the art can refer to the content herein to obtain the high-fidelity DNA polymerase, and realize its application. It should be particularly noted that all similar substitutions and modifications will be apparent to those skilled in the art, and they are all regarded as It is included in the present invention. The preparation method and application of the present invention have been described in the preferred embodiments, and it is obvious that those skilled in the art can make modifications or appropriate changes and combinations to the preparation methods and applications herein without departing from the scope of the invention. The technique of the present invention is applied.
本发明提供的一种高保真 DNA聚合酶及其制备和应用中所用到的试 剂及原料均可由市场购得。 The high fidelity DNA polymerase provided by the present invention and the reagents and materials used in the preparation and use thereof are commercially available.
为了使本技术领域的技术人员能够更好地理解本发明的技术方案,下 面结合实施例, 进一步阐述本发明: 实施例 1 编码 Tco DNA聚合酶的 DNA分子的获得 In order to enable those skilled in the art to better understand the technical solutions of the present invention, the present invention will be further illustrated by the following examples: Example 1 Acquisition of DNA molecules encoding Tco DNA polymerase
菌种 Thermococcus coalescens , 购买于曰本啟生物菌种保藏中心, 其 保藏编号为 JCM: 12540。 将购买的菌种以 12000rpm离心 5min, 弃上清; 细月包沉淀, 参照 Promega公司的 Wizard® Genomic DNA Purification kit提 取基因组 DNA, 其简要步骤如下: The species Thermococcus coalescens, purchased from the Sakamoto Biological Collection, is JCM: 12540. The purchased strain was centrifuged at 12,000 rpm for 5 min, and the supernatant was discarded. The pellet was precipitated and the genomic DNA was extracted with reference to Promega's Wizard® Genomic DNA Purification kit. The brief steps are as follows:
细胞沉淀以 600μΙ^ Nuclei Lysis Solution重悬, 80°C水浴 5min裂解细 胞; 冷却至室温后, 加入 20(^L Protein Preciptitation Solution, 震荡混匀, 冰浴 5min; 12000rpm离心 5min; 吸取上清至另一个干净的离心管, 加入 600μΙ^异丙醇,混匀后冰浴 lOmin; 12000rpm离心 5min;核酸沉淀以 700μ∑ 70%乙醇洗涤两次, 12000rpm离心 5min后, 弃上清, 室温干燥核酸沉淀 lOmin至无酒精味, 加入 50μΙ^ ΤΕ溶解, 即获得该菌种的基因组 DNA。 The cell pellet was resuspended in 600 μΙ^ Nuclei Lysis Solution, and the cells were lysed in a water bath at 80 ° C for 5 min. After cooling to room temperature, add 20 (^L Protein Preciptitation Solution, shake and mix, ice bath for 5 min; centrifuge at 12000 rpm for 5 min; absorb the supernatant to another A clean centrifuge tube, add 600 μΙ isopropyl alcohol, mix and freeze in ice bath for 10 min; centrifuge at 12000 rpm for 5 min; nucleic acid precipitation is washed twice with 700 μ∑ 70% ethanol, centrifuged at 12000 rpm for 5 min, the supernatant is discarded, and the nucleic acid precipitate is dried at room temperature for 10 min. To the taste of no alcohol, add 50 μΙ^ ΤΕ to dissolve, and obtain the genomic DNA of the strain.
获得的 Thermococcus coalescens基因组 DNA未进行全基因组测序, 因此无法得到其 DNA聚合酶的基因序列。 通过 BLAST相似性分析得到 同属已测序菌种 DNA 聚合酶序列相似度高的区域, 设计引物调取 Tco DNA聚合酶编码序列。从 NCBI数据库中搜索已测序古菌 DNA聚合酶全 长基因及其上下游 lkb 左右核苷酸序列, 使用 Clustal W 软件比对 Thermococcus gammatolerans EJ3 、 Pyrococcus yayanosii CHI 、 Thermococcus kodakarensis KOD1 、 Thermococcus onnurineus NA1 、 Thermococcus sibiricus MM 739序歹1 J , 设计引物: The obtained Thermococcus coalescens genomic DNA was not subjected to whole genome sequencing, and thus the gene sequence of its DNA polymerase could not be obtained. By BLAST similarity analysis, the regions with high similarity of DNA polymerase sequences of the same sequence were obtained, and the primers were designed to obtain the Tco DNA polymerase coding sequence. Search the sequenced archaeal DNA polymerase from the NCBI database The long gene and its upstream and downstream lkb nucleotide sequences were designed using the Clustal W software to compare the Thermococcus gammatolerans EJ3, Pyrococcus yayanosii CHI, Thermococcus kodakarensis KOD1, Thermococcus onnurineus NA1, Thermococcus sibiricus MM 739 sequence 歹1 J , and designed primers:
引物 BamHITcoF:具有如 SEQ ID NO:5所示的核苷酸序列; Primer BamHITcoF: having the nucleotide sequence as shown in SEQ ID NO: 5;
引物 Tco493R:具有如 SEQ ID NO:6所示的核苷酸序列; Primer Tco493R: having the nucleotide sequence as shown in SEQ ID NO: 6;
引物 Tco3085F:具有如 SEQ ID NO:7所示的核苷酸序列 ; 引物 TcoDownR:具有如 SEQ ID NO: 8所示的核苷酸序列; Primer Tco3085F: having the nucleotide sequence as shown in SEQ ID NO: 7; primer TcoDownR: having the nucleotide sequence as shown in SEQ ID NO: 8;
以提取的该菌种的基因组 DNA为模板,按照下列体系分别配制 PCR 反应液, 5(^L体系中包含: 上述基因组 DNA 50ng, 引物各 400nmol/L, dNTPs 20(^mol/L , 5 x Prime STAR® Buffer ( Mg2+ plus ) 1 ΟμΙ^ , 宝生物公 司的 PrimeSTAR®HS 0.5μΙ^。 PCR扩增程序为: 98 °C 2min, ( 94 °C 10s; 55 °C 20s; 68 °C 3min ) 25 cycles, 68°C延伸 5min。 PCR产物电泳检测, 使用 引物 BamHITcoF+Tco493R 扩增得到约 2.5kb 片段, 引物 Tco3085F+TcoDownR扩增得到约 3kb片段, 分别回收目的条带, 并分别 使用 Taq DNA聚合酶加 A后,将所得的两个 DNA分子分别连接至 pGM-T 载体中, 将得到阳性克隆测序确认。 Using the extracted genomic DNA of the strain as a template, the PCR reaction solution was prepared according to the following system: 5 (^L system contains: 50 ng of the above genomic DNA, 400 nmol/L of primers, dNTPs 20 (^mol/L, 5 x Prime STAR® Buffer ( Mg 2+ plus ) 1 ΟμΙ^ , BioScience's PrimeSTAR®HS 0.5μΙ^ PCR amplification procedure: 98 °C 2min, (94 °C 10s; 55 °C 20s; 68 °C 3min) 25 cycles, extension at 68 °C for 5 min. PCR product electrophoresis detection, using primer BamHITcoF+Tco493R to amplify a fragment of about 2.5 kb, primer Tco3085F+TcoDownR amplification to obtain a fragment of about 3 kb, respectively recovering the target band, and using Taq separately. After DNA polymerase was added to A, the obtained two DNA molecules were respectively ligated into the pGM-T vector, and the positive clone was confirmed by sequencing.
将上述测序得到的核苷酸序列, 通过 NCBI 搜索, 确认其与 Thermococcus和 Pyrococcus属的编码 DNA聚合酶 B基因相似性最高, 与 Thermococcus sp. AM4 DNA聚合酶 B序列相似性达到 79% , 说明扩增 得到的是 Tco DNA聚合酶的编码序列。分析其序列得知, 其编码的 DNA 聚合酶含有内含肽, 且扩增得到的两个序列无法拼接为全长基因。 The nucleotide sequence obtained by the above sequencing was confirmed by NCBI to be the most similar to the DNA polymerase B gene of Thermococcus and Pyrococcus, and the similarity with Thermococcus sp. AM4 DNA polymerase B was 79%. What is obtained is the coding sequence of Tco DNA polymerase. Analysis of the sequence revealed that the encoded DNA polymerase contained an intein, and the two amplified sequences could not be spliced into a full-length gene.
根据测序结果、 分析结果再设计引物: Design primers based on sequencing results and analysis results:
引物 Tco30F:具有如 SEQ ID NO:9所示的核苷酸序列; Primer Tco30F: having the nucleotide sequence as shown in SEQ ID NO: 9;
以 Tco30F和 TcoDownR为引物,所提取的菌种基因组 DNA为模板, 扩增得到约 3.5kb的片段, 构建至 pGM-T载体后测序, 分析序列发现其 中还含有内含肽。 根据测序结果拼接该 3.5kb 片段与由引物 BamHITcoF+Tco493R扩增得到的约 2.5kb的片段,得到 Tco DNA聚合酶 全长基因, 其全序列包含 6186bp, 其序列如 SEQ ID NO:3所示, 编码的 蛋白共 2061aa, 其氨基酸序列如 SEQ ID NO:4所示。 Using Tco30F and TcoDownR as primers, the extracted genomic DNA was used as a template, and a fragment of about 3.5 kb was amplified and constructed into a pGM-T vector, which was sequenced. The sequence was also found to contain intein. According to the sequencing result, the 3.5 kb fragment was spliced with a fragment of about 2.5 kb amplified by the primer BamHITcoF+Tco493R to obtain Tco DNA polymerase. The full-length gene has a full sequence comprising 6186 bp, the sequence of which is shown in SEQ ID NO: 3, and the encoded protein is 2061 aa, and the amino acid sequence thereof is shown in SEQ ID NO: 4.
将拼接所得的基因序列与 NCBI数据库中其他 DNA聚合酶成熟蛋白 的编码序列比对发现, Tco DNA聚合酶基因被三个内含肽分割为四个编 码框, 去除内含肽后其基因包括 2328bp, 编码的成熟蛋白为 775aa。 Comparing the spliced gene sequence with the coding sequence of other DNA polymerase mature proteins in the NCBI database, the Tco DNA polymerase gene was divided into four coding frames by three inteins, and the gene including 2328 bp was removed after the intein was removed. The encoded mature protein is 775 aa.
根据分析得到的 Tco DNA聚合酶成熟蛋白编码序列, 设计引物分别 扩增四个 ORF: According to the Tco DNA polymerase mature protein coding sequence obtained by the analysis, primers were designed to amplify four ORFs:
引物 Tcol2R:具有如 SEQ ID NO: 10所示的核苷酸序列; Primer Tcol2R: having the nucleotide sequence as shown in SEQ ID NO: 10;
引物 TcoORF12F:具有如 SEQ ID NO: 1 1所示的核苷酸序列; 引物 NTcoORF2R:具有如 SEQ ID NO: 12所示的核苷酸序列; 引物 NTcoORF23F:具有如 SEQ ID NO: 13所示的核苷酸序列; 引物 TcoORF3R:具有如 SEQ ID NO: 14所示的核苷酸序列; Primer TcoORF12F: having the nucleotide sequence shown as SEQ ID NO: 1 1; primer NTcoORF2R: having the nucleotide sequence shown as SEQ ID NO: 12; primer NTcoORF23F: having the sequence shown in SEQ ID NO: 13. Nucleotide sequence; primer TcoORF3R: having the nucleotide sequence shown as SEQ ID NO: 14;
引物 NTcoORF34F:具有如 SEQ ID NO: 15所示的核苷酸序列; 引物 NotlTcoWR:具有如 SEQ ID NO: 16所示的核苷酸序列; 以提取得到的菌种基因组 DNA为模板, PrimeSTAR扩增不同编码框, 其中 BamfflTcoF和 Tcol2R扩增得到约 1.2kb的 ORF1 , TcoORF12F和 NTcoORF2R扩增得到约 250bp的 ORF2, NTcoORF23F和 TcoORF3R扩 增得到约 150bp的 ORF3 , NTcoORF34F和 NotlTcoWR扩增得到约 700bp 的 ORF4。 四个 ORF分别连接至 pGM-T载体, 测序后与拼接的全长基因 比对, 结果显示——对应。 Primer NTcoORF34F: having the nucleotide sequence shown as SEQ ID NO: 15; primer NotlTcoWR: having the nucleotide sequence shown as SEQ ID NO: 16; using the extracted genomic DNA as a template, PrimeSTAR amplification In different coding frames, BamfflTcoF and Tcol2R were amplified to obtain about 1.2 kb of ORF1, TcoORF12F and NTcoORF2R were amplified to obtain about 250 bp of ORF2, NTcoORF23F and TcoORF3R were amplified to obtain about 150 bp of ORF3, NTcoORF34F and NotlTcoWR were amplified to obtain about 700 bp of ORF4. The four ORFs were ligated to the pGM-T vector, sequenced and aligned with the spliced full-length gene, and the results showed - corresponding.
加相同摩尔量的 ORFl、 2、 3、 4片段, 以基因两端引物 BamfflTcoF 和 NotlTcoWR进行重叠 PCR, 拼接得到全长编码区, 其序列如 SEQ ID NO:2所示, 其编码的蛋白质的氨基酸序列如 SEQ ID NO: 1所示, 回收得 到的全长约 2.3kb片段,所得片段即为编码 Tco DNA聚合酶的 DNA分子。 实施例 2含有编码 Tco DNA聚合酶的 DNA分子的重组栽体的构建 Add the same molar amount of ORF1, 2, 3, 4 fragments, and perform overlapping PCR with the primers BamfflTcoF and NotlTcoWR, and splicing to obtain the full-length coding region, whose sequence is shown in SEQ ID NO: 2, and the amino acid of the encoded protein. The sequence is as shown in SEQ ID NO: 1, and the resulting full-length about 2.3 kb fragment is recovered, and the resulting fragment is a DNA molecule encoding Tco DNA polymerase. Example 2 Construction of Recombinant Vector Containing DNA Molecules Encoding Tco DNA Polymerase
将实施例 1获得的全长约 2.3kb的目的片段以 BamH I和 Not I进行 酶切, 连接至同样酶切的含 T7启动子的载体中, 转化至 DH5a感受态细 胞中。 The target fragment of about 2.3 kb in length obtained in Example 1 was digested with BamH I and Not I, ligated into the same digested T7 promoter-containing vector, and transformed into DH5a competent form. In the cell.
通过菌液 PCR鉴定、酶切鉴定和测序验证,证实编码 Tco DNA聚合 酶的基因序列的正确性, 培养验证正确的感受态细胞, 并提取质粒, 所获 得的质粒即为含有编码 Tco DNA聚合酶的 DNA分子的重组载体。 实施例 3表达 Tco DNA聚合酶融合蛋白的转化体的制备 Through the PCR identification, restriction enzyme digestion and sequencing verification, the correctness of the gene sequence encoding Tco DNA polymerase was confirmed, the correct competent cells were cultured and the plasmid was extracted, and the obtained plasmid was encoded with Tco DNA polymerase. Recombinant vector for DNA molecules. Example 3 Preparation of transformants expressing Tco DNA polymerase fusion protein
将实施例 2获得含有编码 Tco DNA聚合酶的 DNA分子的重组载体 转化到宿主细胞 . co/ Rosetta(DE3)中,挑取单菌落培养至 OD6QQ=0.4, 加 入 IPTG,至其浓度为 0.1mmol/L诱导 4h,收集菌体超声破碎, SDS-PAGE 电泳检测目的蛋白的表达, 发现所制备得的转化体能够表达 Tco DNA聚 合酶融合蛋白。 实施例 4 Tco DNA聚合酶的制备 The recombinant vector containing the DNA molecule encoding Tco DNA polymerase was obtained in Example 2 and transformed into a host cell. Co/Rosetta (DE3), single colony culture was picked until OD 6QQ = 0.4, and IPTG was added to a concentration of 0.1 mmol. After induced by /L for 4 h, the cells were sonicated and the expression of the target protein was detected by SDS-PAGE. The obtained transformants were able to express Tco DNA polymerase fusion protein. Example 4 Preparation of Tco DNA Polymerase
将实施例 3获得的能够表达 Tco DNA聚合酶融合蛋白的转化体菌种, 按 1:100接种至 500mL含 200mL LB培养基的雉形瓶中, 加入卡那霉素 至其终浓度为 30mg/L和氯霉素至其终浓度为 34mg/L, 37 °C 200rpm振荡 培养至 OD6。。=0.4,加入 IPTG至其终浓度为 0.1mmol/L, 于 30°C诱导 4h; 收集诱导后菌液, 12000rpm离心 2min, 弃上清, 细胞用 20mL的 pH值 为 7.8, 20mmol/L Tris-HCl, O.lmol/L KCl, 50mmol/L NaCl的 buffer A加 30mmol/L咪唑重悬, 于 -80°C冰箱中冻存 12h; 37°C溶解细胞, 超声波破 碎后于 70°C水浴锅处理 30min, 12000rpm离心 lOmin; 上清过购买于国 家生化工程技术研究中心的镍亲和介质,以含 400mmol/L咪唑的 buffer A 洗脱; 洗脱液过购买于国家生化工程技术研究中心的肝素亲和介质, 以含 200mmol/L、 400mmol/L、 600mmol/L、 lmol/L NaCl的 buffer A进行洗脱; 收集各蛋白峰, 经 SDS-PAGE检测, 发现, 含 200mmol/L NaCl的 buffer A能洗脱部分目的蛋白, 含 400mmol/L NaCl的 buffer A大量洗脱目的蛋 白,将得到的产物透析至 Storage buffer: pH值为 7.4, 20mmol/L Tris-HCl, 0.1 mmol/L EDTA, 0.1% Tween 20, 0.5% Nonidet P40, O.l mol/L KCl, 50%甘油。 The transformant strain capable of expressing the Tco DNA polymerase fusion protein obtained in Example 3 was inoculated to a 500 mL Erlenmeyer flask containing 200 mL of LB medium at a ratio of 1:100, and kanamycin was added thereto to a final concentration of 30 mg/ L and chloramphenicol were brought to a final concentration of 34 mg/L, and cultured at 37 ° C at 200 rpm to OD 6 . . =0.4, IPTG was added to its final concentration of 0.1 mmol/L, and induced at 30 °C for 4 h; the induced bacterial solution was collected, centrifuged at 12,000 rpm for 2 min, the supernatant was discarded, and the cells were pH 7.8 with 20 mL/20 mmol/L Tris- HCl, O.lmol/L KCl, 50mmol/L NaCl buffer A plus 30mmol/L imidazole resuspended, frozen in -80°C refrigerator for 12h; 37°C lysed cells, ultrasonically disrupted at 70°C water bath After treatment for 30 min, centrifuge at 12000 rpm for 10 min; the supernatant was purchased from the National Biochemical Engineering Technology Research Center and eluted with buffer A containing 400 mmol/L imidazole; the eluate was purchased from the National Biochemical Engineering Technology Research Center. The affinity medium was eluted with buffer A containing 200 mmol/L, 400 mmol/L, 600 mmol/L, and 1 mol/L NaCl; each protein peak was collected and detected by SDS-PAGE, and buffer A containing 200 mmol/L NaCl was found. A part of the target protein can be eluted, buffer A containing 400 mmol/L NaCl is eluted with a large amount of the target protein, and the obtained product is dialyzed to Storage buffer: pH 7.4, 20 mmol/L Tris-HCl, 0.1 mmol/L EDTA, 0.1% Tween 20, 0.5% Nonidet P40, Ol mol/L KCl, 50% glycerol.
结果表明成功获得了 Tco DNA聚合酶。 SDS-PAGE显示其纯化结果 如图 1所示: 其中, 泳道 1示纯化的 Tco DNA聚合酶; 泳道 M示蛋白分 子量 Marker。由图可得,所获得的 Tco DNA聚合酶的分子量约为 90KDa, 与其理论大小相一致, 釆用 BandScan软件分析得其纯度达到 95%以上。 实施例 5 Tco DNA聚合酶活性的测定 The results showed that Tco DNA polymerase was successfully obtained. SDS-PAGE showed the purification results as shown in Figure 1: Lane 1 shows purified Tco DNA polymerase; Lane M shows the molecular weight of the marker, Marker. As can be seen from the figure, the obtained Tco DNA polymerase has a molecular weight of about 90 kDa, which is consistent with its theoretical size, and its purity is more than 95% by BandScan software. Example 5 Determination of Tco DNA Polymerase Activity
将实施例 4制备得的 Tco DNA聚合酶以 72°C 30min掺入的核苷酸 量确定其活性, 稀释为 2.5u^L, 以荧光探针法测试其 3,-5,外切酶活性, 结果显示 Tco DNA聚合酶具有较强的校正活性, 说明其扩增保真性能较 好。 为了测试 Tco DNA聚合酶的热稳定性, 将酶于 90°C孵育, 取 0、 1、 2、 3、 4、 5、 6h处理的酶测 DNA聚合酶活性, 结果显示 Tco DNA聚合 酶具有极高的热稳定性, 其 90°C半衰期为 6h。 实施例 6 Tco DNA聚合酶在核酸扩增中的应用 The Tco DNA polymerase prepared in Example 4 was assayed for its activity at a nucleotide concentration of 30 min at 72 ° C, diluted to 2.5 uL, and tested for its 3,-5, exonuclease activity by fluorescent probe method. The results showed that Tco DNA polymerase had strong corrective activity, indicating that its amplification fidelity performance was better. In order to test the thermostability of Tco DNA polymerase, the enzyme was incubated at 90 ° C, and the DNA polymerase activity was measured at 0, 1, 2, 3, 4, 5, 6 h. The results showed that Tco DNA polymerase had a pole. High thermal stability with a 90°C half-life of 6 h. Example 6 Application of Tco DNA Polymerase in Nucleic Acid Amplification
将实施例 4制备得的 Tco DNA聚合酶应用于核酸扩增。 首先, 测试 该 Tco DNA聚合酶在核酸扩增中的反应条件, 以 pUC19质粒为模板,设 计引物 PCR扩增约 2.7kb片段确定其反应的最适 pH值及 K+、NH4 +、Mg2+ 离子浓度。 配制 10 X buffer B: 500mmol/L Tris-HCl, pH值为 7.4〜8.8, 15mmol/L MgCl2,分别添加不同浓度 KC1、 (NH4)2S04,反应体系为 20μΙ^, 其中含: 不同条件的 10 X buffer B 2 L, 2.5mmol/L 的 dNTPs 1.6μΙ^, ΙΟμηιοΙ/L的引物 PAs 0^ , ΙΟμηιοΙ/L的引物 PAa 0.5μΙ, Tco DNA聚合 酶 0.2 L, 15ng^L的 pUC19 0.5μΙ^,按 98°C 2min, ( 98 °C 10s, 60 °C 20s, 68 °C 2min40s )25cycles,最后 68°C延伸 5min,电泳检测,确定最适 buffer。 根据结果,确定 Tco DNA聚合酶的最适反应条件为 10 X Tco buffer: pH值 为 8.4, 500mmol/L Tris-HCl, 150mmol/L KC1, lOOmmol/L (NH4)2S04, 15mmol/L MgCl2。 The Tco DNA polymerase prepared in Example 4 was applied to nucleic acid amplification. First, the reaction conditions of the Tco DNA polymerase in nucleic acid amplification were tested. Using pUC19 plasmid as a template, primers were designed to amplify about 2.7 kb fragment to determine the optimum pH value of the reaction and K + , NH 4 + , Mg 2 . + ion concentration. Prepare 10 X buffer B: 500mmol/L Tris-HCl, pH 7.4~8.8, 15mmol/L MgCl 2 , add different concentrations of KC1, (NH 4 ) 2 S0 4 , the reaction system is 20μΙ^, which contains: different Conditions 10 X buffer B 2 L, 2.5 mmol/L dNTPs 1.6 μΙ^, ΙΟμηιοΙ/L primer PAs 0^ , ΙΟμηιοΙ/L primer PAa 0.5μΙ, Tco DNA polymerase 0.2 L, 15ng^L pUC19 0.5 μΙ^, according to 98 °C 2min, (98 °C 10s, 60 °C 20s, 68 °C 2min40s) 25cycles, the last 68 °C extension 5min, electrophoresis detection, determine the optimal buffer. According to the results, the optimal reaction conditions for determining Tco DNA polymerase were 10 X Tco buffer: pH 8.4, 500 mmol/L Tris-HCl, 150 mmol/L KC1, 100 mmol/L (NH 4 ) 2 S0 4 , 15 mmol/L MgCl 2 .
以所述的 10 x Tco buffer和实施例 4制备得的 Tco DNA聚合酶分别 扩增: 约 800bp P-Actin、 1.3kb、 1.5kb、 3.0kb和 4.1kb β-globin片段的人 基因组 DNA和 8kb片段的 λ基因组, 琼脂糖凝胶电泳结果显示均能很好 地扩增得到目的片段。 琼脂糖凝胶电泳检测, 结果如图 2所示, 其中, 泳 道 Μ示 DNA分子量 Marker; 泳道 1示人基因组 800bp β-Actin片段; 泳 道 2示人基因组 1.3kb β-globin片段;泳道 3示人基因组 1.5kb β-globin片 段;泳道 4示人基因组 3.0kb β-globin片段;泳道 5示 4.1kb β-globin片段; 泳道 6示 λ基因组 8kb片段。 实施例 7 Tco DNA聚合酶对高 GC含量核酸模板和含抑制剂模板的扩增 嗜热微生物为了适应高温环境, 其基因组含有较高的 GC 含量, 如The 10 x Tco buffer and the Tco DNA polymerase prepared in Example 4 were respectively Amplification: Human genomic DNA of about 800 bp P-Actin, 1.3 kb, 1.5 kb, 3.0 kb, and 4.1 kb β-globin fragments and λ genome of 8 kb fragment, agarose gel electrophoresis results showed that they were well amplified. Target segment. As a result of agarose gel electrophoresis, the results are shown in Figure 2, wherein the lanes indicate DNA molecular weight Marker; Lane 1 shows the human genome 800 bp β-Actin fragment; Lane 2 shows the human genome 1.3 kb β-globin fragment; Lane 3 shows the human genome 1.5 kb Β-globin fragment; lane 4 shows the human genomic 3.0 kb β-globin fragment; lane 5 shows the 4.1 kb β-globin fragment; lane 6 shows the λ genome 8 kb fragment. Example 7 Tco DNA Polymerase for High GC Content Nucleic Acid Templates and Amplified Thermophilic Microorganisms Containing Inhibitor Templates In order to adapt to high temperature environments, the genome contains higher GC content, such as
Thermus thermophilus HB8基因组 GC含量约为 70% ,对普通 PCR反应来 说这类模板的扩增存在一定困难;而有的模板在纯化过程中容易受材料来 源中抑制剂污染, 导致 PCR反应失败, 如血液中抗凝剂 EDTA、 肝素等。 The Thermus thermophilus HB8 genome has a GC content of about 70%. It is difficult to amplify such a template for ordinary PCR reactions. However, some templates are susceptible to contamination by inhibitors in the material source during the purification process, resulting in failure of the PCR reaction, such as Anticoagulant EDTA, heparin, etc. in the blood.
为了测试实施例 4制备得的 Tco DNA聚合酶对此类复杂模板和含抑 制剂模板的扩增效果,以含 EDTA的人全血为模板,直接 PCR扩增 237bp 的 SOX21非编码片段; 以大肠杆菌菌液为模板扩增 16srDNA约 1.5kb片 段; 以 Thermus thermophilus HB8基因组为模板, 扩增其约 2kb高 GC片 段,其 GC含量约 72%; 以人基因组为模板,扩增其约 1.5kb高 GC片段, 其 GC含量约为 65.9%; 以购买于天根生化科技 (北京)有限公司的 Pfo DNA聚合酶为对比例, 按各自最适条件扩增, 反应完成后吸取相同量的 产物电泳检测。 Tco DNA聚合酶均能很好地扩增得到目的条带, 而对比 例没有目的条带出现。琼脂糖凝胶电泳检测,结果如图 3所示,其中, 1 ~ 4示 Tco DNA聚合酶扩增结果; a ~ d示 Pfo DNA聚合酶扩增结果; 泳道 M示 DNA分子量 Marker;泳道 1示人全血 237bp片段;泳道 2示大肠杆 菌菌液 1.5kb 16srDNA片段;泳道 3示 Thermus thermophilus HB8基因 2kb 片段; 泳道 4示人基因组 1.5kb片段; 泳道 a示人全血扩增 237bp片段; 泳道 b 示大肠杆菌菌液 1.5kb 16srDNA 片段; 泳道 c 示 Thermus thermophilus HB8基因 2kb片段; 泳道 d示人基因组 1.5kb片段。 实施例 8 不同模板量^ ^下, Tco DNA聚合酶的扩增能力 In order to test the amplification effect of the Tco DNA polymerase prepared in Example 4 on such complex template and inhibitor-containing template, a 237 bp SOX21 non-coding fragment was directly PCR amplified using human whole blood containing EDTA as a template; Approximately 1.5 kb fragment of 16srDNA was amplified by Bacillus lysate as a template; the high-GC fragment of about 2 kb was amplified with the Thermus thermophilus HB8 genome as a template, and its GC content was about 72%. The human genome was used as a template to amplify it to a height of about 1.5 kb. The GC fragment has a GC content of about 65.9%. The Pfo DNA polymerase purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. is used as a comparative solution, and is amplified according to the optimum conditions. After the reaction is completed, the same amount of product is electrophoresed. . Tco DNA polymerase can be well amplified to obtain the desired band, while the comparative example has no target band. As a result of agarose gel electrophoresis, the results are shown in Figure 3. Among them, 1 ~ 4 shows the results of Tco DNA polymerase amplification; a ~ d shows the results of Pfo DNA polymerase amplification; Lane M shows the molecular weight of Marker; 237 bp fragment of whole blood; Lane 2 shows 1.5 kb 16 srDNA fragment of Escherichia coli; Lane 3 shows 2 kb fragment of Thermus thermophilus HB8 gene; Lane 4 shows 1.5 kb fragment of human genome; Lane a shows 237 bp fragment of human whole blood; Lane b shows Escherichia coli 1.5 kb 16 srDNA fragment of bacterial solution; Lane 2 shows a 2 kb fragment of Thermus thermophilus HB8 gene; Lane d shows a human genomic 1.5 kb fragment. Example 8 Amplification ability of Tco DNA polymerase under different template amounts
以 pUC19质粒为模版,釆用实施例 4制备得的 Tco DNA聚合酶扩增 2.7kb的 pUC19质粒。 分别以 10ng、 lng、 0.1ng、 O.Olng, 0.00 lng UC19 质粒, 5(^L反应体系, 实施例 4所制备得的 Tco DNA聚合酶和购买于天 根生化科技 (北京)有限公司的 Pfu DNA聚合酶按各自最适条件扩增, 反应完成后吸取 5μ 产物电泳检测。 琼脂糖凝胶电泳结果显示 Tco DNA 聚合酶的扩增灵敏度远高于 Pfu DNA聚合酶。电泳检测结果如图 4所示, 其中 1 ~ 5示 Tco DNA聚合酶扩增结果; 6 ~ 10示 Pfli DNA聚合酶扩增 结果; 泳道 M示 DNA分子量 Marker; 泳道 1示 10ng的 pUC19;泳道 2 示 lng的 pUC19; 泳道 3示 O. lng的 pUC19; 泳道 4示 O.Olng的 pUC19; 泳道 5示 O.OOlng的 pUC19; 泳道 6示 10ng的 pUC19; 泳道 7示 lng的 pUC19; 泳道 8示 O. lng的 pUC19; 泳道 9示 O.Olng的 pUC19; 泳道 10 示 O.OOlng的 pUC19。 由图 4可观察到 50μΙ^反应体系扩增质粒模板时, Tco DNA聚合酶能检测到 O.Olng pUC19质粒, 而 Pfu DNA聚合酶仅在 10ng的条件下能扩增该质粒。 实施例 9 不同模板量^ ^下, Tco DNA聚合酶的扩增能力 Using the pUC19 plasmid as a template, the 2.7 kb pUC19 plasmid was amplified using the Tco DNA polymerase prepared in Example 4. 10 ng, lng, 0.1 ng, O.Olng, 0.00 lng UC19 plasmid, 5 (^L reaction system, Tco DNA polymerase prepared in Example 4 and Pfu purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. DNA polymerase was amplified according to the optimal conditions. After the reaction was completed, 5μ product electrophoresis was detected. The results of agarose gel electrophoresis showed that the amplification sensitivity of Tco DNA polymerase was much higher than that of Pfu DNA polymerase. 1 to 5 shows Tco DNA polymerase amplification results; 6-10 shows Pfli DNA polymerase amplification results; Lane M shows DNA molecular weight Marker; Lane 1 shows 10 ng of pUC19; Lane 2 shows lng of pUC19; Lane 3 O. lng pUC19; Lane 4 shows O.Ongng pUC19; Lane 5 shows O.OOlng of pUC19; Lane 6 shows 10 ng of pUC19; Lane 7 shows lng of pUC19; Lane 8 shows O. lng of pUC19; Lane 9 O.Olng pUC19; Lane 10 shows O.OOlng pUC19. It can be observed from Figure 4 that when 50μΙ^ reaction system is used to amplify the plasmid template, Tco DNA polymerase can detect O.Olng pUC19 plasmid, while Pfu DNA polymerase Amplify this only under 10 ng conditions The tablets. Example 9 different amounts of template ^ ^, Tco DNA polymerase amplification activity
以人基因组为模板, 釆用实施例 4制备得的 Tco DNA聚合酶扩增人 的 1.3kb片段。 分别以 25ng、 10ng、 5ng、 lng的人基因组 DNA, 50μΙ 反应体系, 实施例 4所制备得的 Tco DNA聚合酶和购买于天根生化科技 (北京)有限公司的 Pfu DNA聚合酶按各自最适条件扩增, 反应完成后 吸取 5 L产物电泳检测。 琼脂糖凝胶电泳结果显示 Tco DNA聚合酶的扩 增灵敏度远高于 Pfo DNA聚合酶。 电泳检测结果如图 5所示, 其中 1 ~ 4 示 Tco DNA聚合酶扩增结果; 5 ~ 8示 Pfli DNA聚合酶扩增结果; 泳道 M示 DNA分子量 Marker;泳道 1示 25ng的人基因组 1.3kb片段;泳道 2 示 10ng的人基因组 1.3kb片段;泳道 3示 5ng的人基因组 1.3kb片段;泳 道 4示 lng的人基因组 1.3kb片段;泳道 5示 25ng的人基因组 1.3kb片段; 泳道 6示 10ng的人基因组 1.3kb片段; 泳道 Ί示 5ng的人基因组 1.3kb 片段; 泳道 8示 lng的人基因组 1.3kb片段。 由图 5可得 Tco DNA聚合 酶能扩增低至 5ng人基因组模板, 而 Pfu DNA聚合酶仅能在最高模板量 25ng时得到微弱扩增。 实施例 10 Tco DNA聚合酶保真性测试 Using the human genome as a template, the human 1.3 kb fragment was amplified using the Tco DNA polymerase prepared in Example 4. 25g, 10ng, 5ng, lng of human genomic DNA, 50μΙ reaction system, Tco DNA polymerase prepared in Example 4 and Pfu DNA polymerase purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. Conditional amplification, after completion of the reaction, 5 L product electrophoresis was detected. Agarose gel electrophoresis results showed that the amplification sensitivity of Tco DNA polymerase was much higher than that of Pfo DNA polymerase. The electrophoresis results are shown in Figure 5, where 1-4 shows Tco DNA polymerase amplification results; 5-8 shows Pfli DNA polymerase amplification results; Lane M shows DNA molecular weight Marker; Lane 1 shows 25 ng human genome 1.3 kb Fragment 2 shows 10 ng of the human genome 1.3 kb fragment; Lane 3 shows 5 ng of the human genome 1.3 kb fragment; Lane 4 shows 1 ng of the human genome 1.3 kb fragment; Lane 5 shows 25 ng of the human genome 1.3 kb fragment; Lane 6 shows a 10 ng human genome 1.3 kb fragment; lanes indicate 5 ng of the human genome 1.3 kb fragment; Lane 8 shows a lng human genome 1.3 kb fragment. From Figure 5, Tco DNA polymerase can amplify as little as 5 ng of human genomic template, while Pfu DNA polymerase can only obtain weak amplification at a maximum template amount of 25 ng. Example 10 Tco DNA polymerase fidelity test
以蓝白斑的方法测试实施例 4所制备得的 Tco DNA聚合酶的保真能 力,以 pUC19质粒为模板, Tco DNA聚合酶、 Taq DNA聚合酶和 Pfu DNA 聚合酶分别扩增全长质粒,测定各酶的扩增倍数。扩增倍数 d,符合公式: 2d=PCR产物量 /起始模板量; Z¾w I消化模板质粒并酶切、 连接后转化 DH5a细胞, 涂布含 IPTG和显色底物 X-Gal的平板, 并计数蓝白斑。 突 变频率 mf, 符合公式 mf=白斑数 /菌落总数。 以公式 ER=mf/(bpxd )计算 不同 DNA聚合酶扩增错误率, DNA聚合酶的保真性为 1/ER, 错误率越 低, 其保真性越好。 结果表明, Tco DNA聚合酶具有良好的保真性能, 其保真性为 Pfu的 1.8倍, Taq的 9.2倍。 实验结果, 图 6所示为三者的 错误率,其中 1示 Taq DNA聚合酶; 2示 Pfli DNA聚合酶; 3示 Tco DNA 聚合酶。 Tco DNA聚合酶的错误率为: 1.2 χ 1θΛ Pfo DNA聚合酶的错 误率为: 2.2 10"6, Taq DNA聚合酶的错误率为: 10.9 10"6„ 根据 DNA 聚合酶的保真性为 1/ER得: Tco DNA聚合酶的保真性为 Pfu DNA聚合 酶的 1.8倍, 为 Taq DNA聚合酶的 9.2倍。 由以上实施例可知,本发明所公开的一种高保真 DNA聚合酶,即 Tco DNA聚合酶, 具有扩增不同模板和片段的能力, 同时对复杂模板和含抑 制剂模板也能得到较好的结果, 且具有高保真扩增能力, 适合各类 PCR 及对扩增保真性要求较高的实验, 也适合作为 PCR扩增试剂盒中高保真 DNA聚合酶。 The fidelity of the Tco DNA polymerase prepared in Example 4 was tested by the method of blue-white spot, and the full-length plasmid was amplified by using TUC DNA polymerase, Taq DNA polymerase and Pfu DNA polymerase, respectively, using the pUC19 plasmid as a template. Amplification factor of each enzyme. The amplification factor d is in accordance with the formula: 2 d = amount of PCR product / amount of starting template; Z3⁄4w I digested the template plasmid and digested, ligated and transformed DH5a cells, and coated a plate containing IPTG and the chromogenic substrate X-Gal. And count blue and white spots. The mutation frequency mf, in accordance with the formula mf = white spot number / total number of colonies. The error rate of different DNA polymerase amplification was calculated by the formula ER=mf/(bpxd). The fidelity of DNA polymerase was 1/ER, and the lower the error rate, the better the fidelity. The results showed that Tco DNA polymerase had good fidelity performance, and its fidelity was 1.8 times that of Pfu and 9.2 times that of Taq. The experimental results, Figure 6 shows the error rate of the three, where 1 shows Taq DNA polymerase; 2 shows Pfli DNA polymerase; 3 shows Tco DNA polymerase. The error rate of Tco DNA polymerase is: 1.2 χ 1θΛ The error rate of Pfo DNA polymerase is: 2.2 10" 6 , the error rate of Taq DNA polymerase is: 10.9 10" 6 „ According to the fidelity of DNA polymerase is 1/ ER: The fidelity of Tco DNA polymerase is 1.8 times that of Pfu DNA polymerase and 9.2 times that of Taq DNA polymerase. From the above examples, a high-fidelity DNA polymerase disclosed in the present invention, namely Tco DNA, is known. Polymerase, which has the ability to amplify different templates and fragments, and also has good results for complex templates and inhibitor-containing templates, and has high fidelity amplification ability, suitable for all kinds of PCR and requirements for amplification fidelity. High experiments are also suitable as high-fidelity DNA polymerases in PCR amplification kits.
以上仅是本发明的优选实施方式,应当指出的是,上述优选实施方式 不应视为对本发明的限制,本发明的保护范围应当以权利要求所限定的范 围为准。对于本技术领域的普通技术人员来说,在不脱离本发明的精神和 范围内,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的 保护范围。 The above is only a preferred embodiment of the present invention, and it should be noted that the above-described preferred embodiments should not be construed as limiting the scope of the invention. The square is subject to accuracy. It will be apparent to those skilled in the art that various modifications and improvements can be made without departing from the spirit and scope of the invention.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310268966.9A CN104250641B (en) | 2013-06-28 | 2013-06-28 | A kind of high-fidelity DNA polymerase and its preparation and application |
| CN201310268966.9 | 2013-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2014205882A1 true WO2014205882A1 (en) | 2014-12-31 |
Family
ID=52140918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2013/079428 Ceased WO2014205882A1 (en) | 2013-06-28 | 2013-07-16 | High-fidelity dna polymerase, and preparation and use thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN104250641B (en) |
| WO (1) | WO2014205882A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106282215A (en) * | 2016-08-26 | 2017-01-04 | 周辉 | A kind of preparation method of high-fidelity DNA polymerase powdered reagent box |
| CN109957557B (en) * | 2017-12-26 | 2023-01-06 | 广州市锐博生物科技有限公司 | DNA polymerase and method for producing same |
| CN113755465A (en) * | 2021-09-23 | 2021-12-07 | 武汉爱博泰克生物科技有限公司 | Chimeric DNA polymerase and preparation method thereof |
| CN119895036A (en) * | 2022-12-21 | 2025-04-25 | 深圳华大生命科学研究院 | DNA polymerase and application thereof |
| WO2024138419A1 (en) * | 2022-12-28 | 2024-07-04 | 深圳华大生命科学研究院 | Polypeptide having dna polymerase activity and use thereof |
| CN116574710A (en) * | 2023-04-23 | 2023-08-11 | 天津中合基因科技有限公司 | DNA polymerase with strand displacement function and application thereof |
| WO2025129708A1 (en) * | 2023-12-22 | 2025-06-26 | 深圳华大生命科学研究院 | Dna polymerase and use thereof |
| WO2025137876A1 (en) * | 2023-12-26 | 2025-07-03 | 深圳华大生命科学研究院 | Isolated polypeptide, preparation method, and use |
| CN119193528B (en) * | 2024-10-12 | 2025-10-21 | 自然资源部第三海洋研究所 | A high-fidelity and high-amplification-efficiency high-temperature-resistant DNA polymerase, its preparation method, PCR amplification method, and application |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1993468A (en) * | 2004-06-04 | 2007-07-04 | 宝生物工程株式会社 | Polypeptides having DNA polymerase activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1417338A (en) * | 2001-11-06 | 2003-05-14 | 杭州华大基因研发中心 | High temperature-resisting DNA polymerase gene sequence and its encoded polypeptide and prepn process |
| CA2742593C (en) * | 2008-11-03 | 2020-05-05 | Bjarne Faurholm | Chimeric dna polymerases |
| KR20110102467A (en) * | 2009-01-15 | 2011-09-16 | 홋카이도 미쓰이가가쿠 가부시키가이샤 | Enzyme preparation containing heat-resistant DNA polymerase, its manufacturing method, and detection method of a target organism |
-
2013
- 2013-06-28 CN CN201310268966.9A patent/CN104250641B/en active Active
- 2013-07-16 WO PCT/CN2013/079428 patent/WO2014205882A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1993468A (en) * | 2004-06-04 | 2007-07-04 | 宝生物工程株式会社 | Polypeptides having DNA polymerase activity |
Non-Patent Citations (3)
| Title |
|---|
| DATABASE GENBANK 10 June 2013 (2013-06-10), ZIVANOVIC, Y. ET AL.: "DNA-directed DNA polymerase, B family (pol) [Thermococcus gammatolerans EJ3].", accession no. P_002959821 * |
| KUWABARA, T. ET AL.: "Thermococcus coalescens sp. nov., a cell -fusing hyperthermophilic archaeon from Suiyo Seamount.", INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY., vol. 55, 30 November 2005 (2005-11-30), pages 2507 - 2514 * |
| LEE, J. I. ET AL.: "Characterization and PCR optimization of the thermostable family B DNA polymerase from Thermococcus guaymasensis.", ENZYME AND MICROBIAL TECHNOLOGY., vol. 45, no. 2, 7 August 2009 (2009-08-07), pages 103 - 111 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104250641A (en) | 2014-12-31 |
| CN104250641B (en) | 2017-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014205882A1 (en) | High-fidelity dna polymerase, and preparation and use thereof | |
| CN105039278B (en) | Saltant type Taq archaeal dna polymerases and its preparation method and application | |
| CN112661861A (en) | Recombinant polymerase, encoding gene, preparation method, vector, kit and application | |
| CN106399299A (en) | Method for improving activity of large-fragment Geobacillus stearothermophilus (Bst) DNA polymerase through point mutation and application | |
| CN118480527B (en) | Taq DNA polymerase mutants and their applications | |
| CN116463312A (en) | Bst DNA polymerase mutant, fusion protein and application thereof | |
| CN116064462A (en) | Taq DNA polymerase mutant and preparation method thereof | |
| CN107287230B (en) | Plasmid vector and construction method thereof | |
| CN106434732A (en) | Expression vector applicable to corynebacterium glutamicum and application thereof | |
| CN103881989B (en) | A DNA polymerase with processivity and salt tolerance | |
| CN103966244A (en) | DNA polymerase coding DNA, enzyme coded thereby, and application and preparation method of DNA polymerase | |
| CN103898131A (en) | DNA of coded DNA polymerase separated from thermophilic bacteria | |
| CN109504748A (en) | A method of it is specific in SNPs detection to improve RAA technology | |
| JP2017178804A (en) | Fusion protein | |
| CN117821412B (en) | A dCE-KOD DNA polymerase and its preparation method and application | |
| CN108359678A (en) | A kind of plasmid vector and its construction method of energy high-efficient cloning and temperature-induced expression | |
| CN104593491A (en) | Method for improving PCR amplification sensitivity by using integrated host factor | |
| CN109486779B (en) | DNA methyltransferase and soluble heterologous expression and separation and purification method thereof | |
| BR112018067704B1 (en) | POLYPHOSPHATE-DEPENDENT GLICOKINASE AND METHOD FOR THE PREPARATION OF GLUCOSE 6-PHOSPHATE USING THE SAME | |
| CN118530925A (en) | Construction method of leguminous plant stress-resistant efficient genetic engineering rhizobium strain and special strain | |
| CN114480345B (en) | MazF mutant, recombinant vector, recombinant engineering bacterium and application thereof | |
| CN114774421B (en) | Zymomonas mobilis endogenous promoter mutant | |
| CN102533769B (en) | Low-temperature promoter of pseudomonassp and application of low-temperature promoter | |
| CN104480081A (en) | Sso7d-Sau recombinant DNA polymerase | |
| CN119751604B (en) | Optimized SSo d structural domain, improved Taq DNA polymerase and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13888001 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 13888001 Country of ref document: EP Kind code of ref document: A1 |